Fulgent Genetics
FLGT
235 hedge funds and large institutions have $508M invested in Fulgent Genetics in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 87 increasing their positions, 67 reducing their positions, and 50 closing their positions.
59% more call options, than puts
Call options by funds: $22.2M | Put options by funds: $14M
30% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 67
1.13% more ownership
Funds ownership: 42.94% → 44.07% (+1.1%)
10% less funds holding
Funds holding: 262 → 235 (-27)
28% less capital invested
Capital invested by funds: $711M → $508M (-$202M)
52% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 50
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$14.5M |
| 2 |
BlackRock
New York
|
+$7.47M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$6.18M |
| 4 |
JP Morgan Chase
New York
|
+$5.55M |
| 5 |
Amundi
Paris,
France
|
+$4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$34.3M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$6.68M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.32M |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$2.11M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.92M |
FLGT Hedge Fund Activity: Q3 2022 in Review
235 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2022, worth a combined $508M — down 28% from $711M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of FLGT and 24 opened new positions — a net loss of 26 holders — while 67 trimmed existing stakes and 87 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $14.5M. The largest seller was Park West Asset Management, exiting entirely with an estimated $34.3M sold.
- 235 institutional investors held Fulgent Genetics (FLGT) as of Q3 2022, down from 262 in Q2 2022.
- Funds reported $508M of Fulgent Genetics stock for Q3 2022, down 28% quarter-over-quarter.
- 24 funds opened new Fulgent Genetics positions in Q3 2022 and 50 closed out, a net change of -26 holders.
- The largest Fulgent Genetics buyer in Q3 2022 was Dimensional Fund Advisors, an estimated $14.5M added.
- The largest Fulgent Genetics seller in Q3 2022 was Park West Asset Management, an estimated $34.3M sold.
Based on aggregated 13F filings for Q3 2022.